Skip to main content
59°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CONMED Corporation - Common Stock
(NY:
CNMD
)
60.39
+1.54 (+2.62%)
Official Closing Price
Updated: 4:10 PM EDT, Mar 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CONMED Corporation - Common Stock
< Previous
1
2
3
Next >
CONMED CORP (NYSE:CNMD) appears to be flying under the radar despite its strong fundamentals.
Today 6:10 EDT
CONMED CORP has caught the attention as a great value stock. NYSE:CNMD excels in profitability, solvency, and liquidity, all while being very reasonably priced.
Via
Chartmill
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
March 28, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
March 24, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
March 21, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Breaking Down Conmed: 4 Analysts Share Their Views
February 06, 2025
Via
Benzinga
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
March 10, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
March 05, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst...
Via
StockStory
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
February 06, 2025
Via
Benzinga
These Analysts Slash Their Forecasts On Conmed After Q4 Results
February 06, 2025
Via
Benzinga
Conmed Q4 Earnings Assessment
February 05, 2025
Via
Benzinga
Insights into Conmed Q4 Earnings
February 05, 2025
Via
Benzinga
Earnings Scheduled For February 5, 2025
February 05, 2025
Via
Benzinga
Assessing Conmed: Insights From 6 Financial Analysts
October 04, 2024
Via
Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops
February 05, 2025
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue...
Via
StockStory
Top 3 Health Care Stocks That May Dip This Month
November 25, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Conmed Through Analyst Insights
August 01, 2024
Via
Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Misses Revenue for Q2 2024
July 31, 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
May 19, 2024
Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains.
Via
InvestorPlace
Analyst Scoreboard: 5 Ratings For Conmed
April 25, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Conmed
February 01, 2024
Via
Benzinga
Recap: Conmed Q4 Earnings
January 31, 2024
Via
Benzinga
Conmed's Earnings: A Preview
January 30, 2024
Via
Benzinga
$1M Bet On Skyworks Solutions? Check Out These 3 Stocks Insiders Are Buying
May 03, 2024
Via
Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Beats Revenue for Q1 2024
April 24, 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Retirement Stocks to Buy at a 52-Week Low in March
March 25, 2024
Investing in these retirement stocks to buy at one-year lows presents a prime opportunity for long-term gains.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
These Analysts Revise Their Forecasts On CONMED After Q4 Results
February 01, 2024
CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday.
Via
Benzinga
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 01, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Conmed's Earnings: A Preview
October 24, 2023
Via
Benzinga
Analyst Ratings for Conmed
July 24, 2023
Via
Benzinga
Earnings Scheduled For January 31, 2024
January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.